v3.26.1
Revenue and Segment Information - Summary of Significant Segment Expenses (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]            
Total revenue $ 189,948   $ 157,370   $ 363,881 $ 300,907
Total cost of revenue 76,750   60,781   149,522 116,090
Research, development and clinical trials:            
Research, development and clinical trials 31,632   15,934   56,511 33,094
Selling, general and administrative:            
Selling, general and administrative 57,830   44,088   120,815 87,713
Other segment items [1] 9,054   1,660   15,036 3,421
Net income 14,682 $ 7,315 34,907 $ 25,682 21,997 60,589
Cost of net product revenue            
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]            
Total revenue 111,158   96,100   219,130 184,334
Total cost of revenue 25,566   19,421   49,874 35,733
Cost of service revenue            
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]            
Total revenue 78,790   61,270   144,751 116,573
Total cost of revenue 51,184   41,360   99,648 80,357
Personnel related (including stock-based compensation expense)            
Research, development and clinical trials:            
Research, development and clinical trials 7,754   5,964   16,162 12,216
Selling, general and administrative:            
Selling, general and administrative 30,931   27,307   65,037 54,978
Laboratory supplies and research materials            
Research, development and clinical trials:            
Research, development and clinical trials 6,218   5,206   10,359 10,162
Consulting and third-party services            
Research, development and clinical trials:            
Research, development and clinical trials 12,866   2,302   21,275 6,475
Clinical trials costs            
Research, development and clinical trials:            
Research, development and clinical trials 1,615   267   2,320 348
Professional and consultant fees            
Selling, general and administrative:            
Selling, general and administrative 8,263   5,696   17,525 13,254
NOP support            
Selling, general and administrative:            
Selling, general and administrative 1,923   1,932   3,503 4,338
Tradeshows and conferences            
Selling, general and administrative:            
Selling, general and administrative 1,721   1,549   2,990 1,975
Facility and IT related and other            
Research, development and clinical trials:            
Research, development and clinical trials 3,179   2,195   6,395 3,893
Selling, general and administrative:            
Selling, general and administrative 8,648   5,960   16,440 10,282
Depreciation and amortization expense            
Selling, general and administrative:            
Selling, general and administrative 4,289   $ 1,644   10,351 $ 2,886
Transaction-related costs            
Selling, general and administrative:            
Selling, general and administrative 1,745       4,452  
Headquarters relocation costs            
Selling, general and administrative:            
Selling, general and administrative 65       272  
ERP implementation costs            
Selling, general and administrative:            
Selling, general and administrative $ 245       $ 245  
[1] Other segment items include interest income, interest expense, foreign currency exchange gains and losses and income taxes. See the condensed consolidated financial statements for other financial information regarding the Company’s operating segment.